Sentinel lymph node biopsy in early breast cancer surgery - Working with the risks of vital blue dye to reap the benefits

European Journal of Surgical Oncology

Volumn 37, Issue 2, 2011, Pages 101-108

  White, V ^a   Harvey, J R ^b   Griffith, C D M ^b   Youssef, M ^a   Carr, M ^a  

^a WANSBECK GENERAL HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Anaphylaxis; Early breast cancer; Isosulfan blue; Patent blue V dye; Sentinel lymph node biopsy; Vital blue dyes

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; DISULFINE BLUE; HISTAMINE H2 RECEPTOR ANTAGONIST; ISOSULFAN BLUE; METHYLENE BLUE; RADIOACTIVE NANOCOLLOID; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANAPHYLAXIS; BREAST CANCER; BREAST SURGERY; CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; ERYTHEMA; HUMAN; LYMPHOSCINTIGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SKIN NECROSIS; SKIN ULCER; TISSUE NECROSIS;

ANAPHYLAXIS; BREAST NEOPLASMS; COLORING AGENTS; FEMALE; HUMANS; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 79251596722     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.12.007     Document Type: Review

References (82)

1. E.A. Gould, T. Winship, P.H. Philbin, and H.H. Kerr Observations on a "sentinel node" in cancer of the parotid Cancer 13 1960 77 78
2. R.M. Cabanas An approach for the treatment of penile carcinoma Cancer 39 2 1977 456 466
3. D.L. Morton, D.R. Wen, and J.H. Wong Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 4 1992 392 399
4. A.J. Cochran, D.R. Wen, and D.L. Morton Management of the regional lymph nodes in patients with cutaneous malignant melanoma World J Surg 16 2 1992 214 221
5. D.L. Morton, J.F. Thompson, and R. Essner Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group Ann Surg 230 4 1999 453 463 discussion 463-5
6. A.E. Giuliano, D.M. Kirgan, J.M. Guenther, and D.L. Morton Lymphatic mapping and sentinel lymphadenectomy for breast cancer Ann Surg 220 3 1994 391 398 discussion 398-401
7. D. Krag, D. Weaver, and T. Ashikaga The sentinel node in breast cancer-a multicenter validation study N Engl J Med 339 14 1998 941 946
8. A.D. Purushotham, S. Upponi, and M.B. Klevesath Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial J Clin Oncol 23 19 2005 4312 4321
9. R.E. Mansel, L. Fallowfield, and M. Kissin Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial J Natl Cancer Inst 98 9 2006 599 609
10. G. Gill Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial Ann Surg Oncol 16 2 2009 266 275
11. G.H. Lyman, A.E. Giuliano, and M.R. Somerfield American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 30 2005 7703 7720
12. Association of Breast Surgery Surgical guidelines for the management of breast cancer Eur J Surg Oncol 35 Suppl. 1 2009 1 22
13. S.K. Somasundaram, D.W. Chicken, and M.R. Keshtgar Detection of the sentinel lymph node in breast cancer Br Med Bull 84 2007 117 131
14. P.J. Borgstein, R. Pijpers, E.F. Comans, P.J. van Diest, R.P. Boom, and S. Meijer Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection J Am Coll Surg 186 3 1998 275 283
15. D.W. Knapp, L.G. Adams, and A.M. Degrand Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light Eur Urol 52 6 2007 1700 1708
16. P.J. Borgstein, S. Meijer, R.J. Pijpers, and P.J. van Diest Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method Ann Surg 232 1 2000 81 89
17. T.S. Sadiq, W.W. Burns 3rd, D.J. Taber, L. Damitz, and D.W. Ollila Blue urticaria: a previously unreported adverse event associated with isosulfan blue Arch Surg 136 12 2001 1433 1435
18. E. Orsenigo, V. Tomajer, and S. Di Palo Sentinel node mapping during laparoscopic distal gastrectomy for gastric cancer Surg Endosc 22 1 2008 118 121
19. O.E. Nieweg, S.H. Estourgie, M.C. van Rijk, and B.B. Kroon Rationale for superficial injection techniques in lymphatic mapping in breast cancer patients J Surg Oncol 87 4 2004 153 156
20. L. Celliers, and G.B. Mann Alternative sites of injection for sentinel lymph node biopsy in breast cancer ANZ J Surg 73 8 2003 600 604
21. J.F. Rodier, M. Velten, and M. Wilt Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial J Clin Oncol 25 24 2007 3664 3669
22. K.M. McMasters, S.L. Wong, and R.C. Martin 2nd Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study Ann Surg 233 5 2001 676 687
23. G. Peley, I. Sinkovics, J. Toth, E. Farkas, S. Keresztes, and I. Koves Subareolar injection of radioactive colloid for sentinel lymph node identification in breast cancer patients Am Surg 70 7 2004 625 629
24. M.D. McCarter, H. Yeung, S. Yeh, J. Fey, P.I. Borgen, and H.S. Cody 3rd Localization of the sentinel node in breast cancer: identical results with same-day and day-before isotope injection Ann Surg Oncol 8 8 2001 682 686
25. K. Motomura, Y. Komoike, and Y. Hasegawa Intradermal radioisotope injection is superior to subdermal injection for the identification of the sentinel node in breast cancer patients J Surg Oncol 82 2 2003 91 96 discussion 96-7
26. Sappey Thesis Medecine 1834 Rignoux Imprimeur de la Faculte de Medecine Paris
27. U. Veronesi, G. Paganelli, and V. Galimberti Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes Lancet 349 9069 1997 1864 1867
28. J.I. Hirsch, J. Tisnado, S.R. Cho, and M.C. Beachley Use of isosulfan blue for identification of lymphatic vessels: experimental and clinical evaluation AJR Am J Roentgenol 139 6 1982 1061 1064
29. C. Tsopelas, E. Bevington, and J. Kollias 99mTc-Evans blue dye for mapping contiguous lymph node sequences and discriminating the sentinel lymph node in an ovine model Ann Surg Oncol 13 5 2006 692 700
30. D.L. Hepner, and M.C. Castells Anaphylaxis during the perioperative period Anesth Analg 97 5 2003 1381 1395
31. L. Tafra, D.R. Lannin, and M.S. Swanson Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye Ann Surg 233 1 2001 51 59
32. A.B. Chagpar, R.C. Martin, and C.R. Scoggins Factors predicting failure to identify a sentinel lymph node in breast cancer Surgery 138 1 2005 56 63
33. B. Chua, I.A. Olivotto, J.C. Donald, A.H. Hayashi, N. Davis, and C.H. Rusnak Practice patterns of lymph-node mapping and sentinel-node biopsy for breast cancer in British Columbia Can J Surg 46 4 2003 273 278
34. T.M. Breslin, L. Cohen, and A. Sahin Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer J Clin Oncol 18 20 2000 3480 3486
35. J.J. Albertini, G.H. Lyman, and C. Cox Lymphatic mapping and sentinel node biopsy in the patient with breast cancer Jama 276 22 1996 1818 1822
36. C.E. Cox, S. Pendas, and J.M. Cox Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer Ann Surg 227 5 1998 645 651 discussion 651-3
37. G. Canavese, M. Gipponi, and A. Catturich Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients J Surg Oncol 77 2 2001 81 87 discussion 88
38. L. Barthelmes, A. Goyal, R.G. Newcombe, F. McNeill, and R.E. Mansel Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience Eur J Surg Oncol 36 4 2010 399 403
39. W.L. Kopp Anaphylaxis from alphazurine 2G during lymphography Jama 198 6 1966 668 669
40. B. Cady Consensus on sentinel node biopsy Breast J 8 3 2002 123 125
41. L.L. Montgomery, A.C. Thorne, and K.J. Van Zee Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer Anesth Analg 95 2 2002 385 388 [table of contents]
42. L.G. Wilke, L.M. McCall, and K.E. Posther Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial Ann Surg Oncol 13 4 2006 491 500
43. D.N. Krag, S.J. Anderson, and T.B. Julian Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial Lancet Oncol 8 10 2007 881 888
44. C.E. Cox, C.J. Salud, and M.A. Harrinton The role of selective sentinel lymph node dissection in breast cancer Surg Clin North Am 80 6 2000 1759 1777
45. V.M. Cimmino, A.C. Brown, and J.F. Szocik Allergic reactions to isosulfan blue during sentinel node biopsy-a common event Surgery 130 3 2001 439 442
46. D. Albo, J.D. Wayne, and K.K. Hunt Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer Am J Surg 182 4 2001 393 398
47. T.A. King, J.V. Fey, and K.J. Van Zee A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer Ann Surg Oncol 11 5 2004 535 541
48. I.K. Komenaka, V.P. Bauer, and F.R. Schnabel Allergic reactions to isosulfan blue in sentinel lymph node mapping Breast J 11 1 2005 70 72
49. G.C. Hsu, C.H. Ku, J.C. Yu, C.B. Hsieh, C.P. Yu, and T.Y. Chao Application of intraoperative ultrasound to nonsentinel node assessment in primary breast cancer Clin Cancer Res 12 12 2006 3746 3753
50. A.S. Hunting, A. Nopp, S.G. Johansson, F. Andersen, V. Wilhelmsen, and A.B. Guttormsen Anaphylaxis to patent blue V. I. Clinical aspects Allergy 65 1 2010 117 123
51. A. Goyal, R.G. Newcombe, A. Chhabra, and R.E. Mansel Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase Breast Cancer Res Treat 99 2 2006 203 208
52. S. Thevarajah, T.L. Huston, and R.M. Simmons A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer Am J Surg 189 2 2005 236 239
53. N.F. Quiney, M.W. Kissin, and I. Tytler Anaphylactic reaction to isosulphan blue Br J Anaesth 90 1 2003 105 106
54. O. Olsha, and M. Carmon Blue hives localized to the opposite arm after patent blue v injection for lymph node mapping in breast cancer Breast J 11 6 2005 468
55. P. Efron, E. Knudsen, S. Hirshorn, and E.M. Copeland Anaphylactic reaction to isosulfan blue used for sentinel node biopsy: case report and literature review Breast J 8 6 2002 396 399
56. T.B. Stefanutto, W.A. Shapiro, and P.M. Wright Anaphylactic reaction to isosulphan blue Br J Anaesth 89 3 2002 527 528
57. D.A. Burton, and J.N. Cashman Allergic reaction to nanocolloid during lymphoscintigraphy for sentinel lymph node biopsy Br J Anaesth 90 1 2003 105
58. D.W. Chicken, R. Mansouri, P.J. Ell, and M.R. Keshtgar Allergy to technetium-labelled nanocolloidal albumin for sentinel node identification Ann R Coll Surg Engl 89 2 2007 W12 W13
59. U. Veronesi, G. Paganelli, and G. Viale A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 6 2003 546 553
60. A.M. Derossis, J. Fey, and H. Yeung A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer J Am Coll Surg 193 5 2001 473 478
61. S.K. Boolbol, J.V. Fey, and P.I. Borgen Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma Ann Surg Oncol 8 1 2001 20 24
62. T.M. Tuttle, M. Colbert, and R. Christensen Subareolar injection of 99mTc facilitates sentinel lymph node identification Ann Surg Oncol 9 1 2002 77 81
63. C.T. Wu, E.T. Morita, and P.A. Treseler Failure to harvest sentinel lymph nodes identified by preoperative lymphoscintigraphy in breast cancer patients Breast J 9 2 2003 86 90
64. T. Kim, A.E. Giuliano, and G.H. Lyman Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis Cancer 106 1 2006 4 16
65. P. Varghese, A. Mostafa, and A.T. Abdel-Rahman Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer Eur J Surg Oncol 33 2 2007 147 152
66. C. Tsopelas, and R. Sutton Why certain dyes are useful for localizing the sentinel lymph node J Nucl Med 43 10 2002 1377 1382
67. K. Eldrageely, M.P. Vargas, and I. Khalkhali Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue Am Surg 70 10 2004 872 875
68. B. Stradling, G. Aranha, and S. Gabram Adverse skin lesions after methylene blue injections for sentinel lymph node localization Am J Surg 184 4 2002 350 352
69. M. Salhab, W. Al Sarakbi, and K. Mokbel Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer Int Semin Surg Oncol 2 2005 26
70. P.M. Perry, and E. Meinhard Nectotic subcutaneous abscesses following injections of methylene blue Br J Clin Pract 28 8 1974 289 291
71. P.C. Johnson, and R. Sheppeck The dark side of methylene blue Plast Reconstr Surg 83 6 1989 1076 1077
72. L.G. Quadros, and L. Gebrim The sentinel lymph node biopsy in breast cancer in the practice of the Brazilian Gynecologist: a revision. Rev. Bras. Ginecol Obstet 29 3 2007 158 164
73. W.D. Blessing, A.J. Stolier, S.C. Teng, J.S. Bolton, and G.M. Fuhrman A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping Am J Surg 184 4 2002 341 345
74. M. Golshan, and F. Nakhlis Can methylene blue only be used in sentinel lymph node biopsy for breast cancer? Breast J 12 5 2006 428 430
75. R.M. Simmons, S.M. Smith, and M.P. Osborne Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization Breast J 7 3 2001 181 183
76. C.P. Raut, M.D. Daley, and K.K. Hunt Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis J Clin Oncol 22 3 2004 567 568
77. A.D. Purushotham, R.D. Macmillan, and G.C. Wishart Advances in axillary surgery for breast cancer-time for a tailored approach Eur J Surg Oncol 31 9 2005 929 931
78. T.J. Selman, C. Mann, J. Zamora, T.L. Appleyard, and K. Khan Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis Cmaj 178 7 2008 855 862
79. L.P. Kowalski, and A. Sanabria Elective neck dissection in oral carcinoma: a critical review of the evidence Acta Otorhinolaryngol Ital 27 3 2007 113 117
80. A. Stojadinovic, A. Nissan, and M. Protic Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01 Ann Surg 245 6 2007 846 857
81. W. Kelder, A.E. Braat, and A. Karrenbeld The sentinel node procedure in colon carcinoma: a multi-centre study in The Netherlands Int J Colorectal Dis 22 12 2007 1509 1514
82. E. Tousimis, K.J. Van Zee, and J.V. Fey The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers J Am Coll Surg 197 4 2003 529 535